Search for: "J. H.1" Results 2841 - 2860 of 4,859
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Nov 2019, 12:27 am by Robin
The Welsh tenant fees ban came into force on 1 September 2019, applying to assured shorthold tenancies granted from that date onwards for properties in Wales. [read post]
2 Jan 2007, 10:07 am
Circuit chief judges on the brief, Abner J. [read post]
27 Mar 2014, 6:13 pm by Kelly Phillips Erb
If more than 21 days have gone by and you haven’t received your refund, you can try giving the IRS a call at 1-800-829-1040 but be prepared to wait! [read post]
28 Oct 2007, 7:25 pm
OCT 182007OFFICE or T1"'1;,:,,1{STATE OF MISSISSIPPI SUPREME CC! [read post]
20 Feb 2011, 7:14 am by The Legal Blog
.-(1) Save as otherwise expressly provided in this Act,-(a) any text, rule or interpretation of Hindu law or any custom or usage as part of that law in force immediately before the commencement of this Act shall cease to have effect with respect to any matter for which provision is made in this Act;(b) any other law in force immediately before the commencement of this Act shall cease to apply to Hindus in so far as it is inconsistent with any of the provisions contained in this Act.2. [read post]
19 Sep 2010, 9:00 am by dnt.atheniense@gmail.com
Para o associado há um desconto especial”, explicou Henrique Carregal. [read post]
21 Oct 2018, 9:30 pm by Mark Nakahara
A recent article by Huyen Pham of the Texas A&M University School of Law and Van H. [read post]
25 Dec 2012, 7:05 pm by Douglas
Ainda que tenhamos uma competência mais ampla, não há autorização constitucional de dissídio coletivo para trabalhador autônomo”. [read post]
11 Mar 2013, 7:32 am by Allison Trzop
Writing at The Huffington Post, Ryan J. [read post]
4 Jan 2012, 5:02 pm by FDABlog HPM
The legal basis for FDA’s decision is not stated in the letters, but may be based on FDC Act § 505(j)(4)(H), which states that FDA shall approve an ANDA unless the Agency finds that: information submitted in the application or any other information available to the Secretary shows that (i) the inactive ingredients of the drug are unsafe for use under the conditions prescribed, recommended, or suggested in the labeling proposed for the drug, or (ii) the composition of… [read post]